This inventor holds 1 USPTO granted patent. Top assignee: Carlo Erba. Active years: 1977.
Company Filing History:
Years Active: 1977
Title: Aldo Ermili: Innovator in Antidepressant Compounds
Introduction
Aldo Ermili is a notable inventor based in Genoa, Italy. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds aimed at treating depression. His innovative work has the potential to impact the lives of many individuals suffering from this condition.
Latest Patents
Aldo Ermili holds a patent for "1-Oxo-1H-naphtho [2,1-b] pyran derivatives for treating depression." This patent includes compounds such as 1-oxo-3-(N-methyl-N-ethyl) amino-1H-naphtho [2,1-b] pyran. These derivatives are designed to be active on the central nervous system, functioning as effective antidepressive agents. The pharmaceutical compositions containing these compounds offer a new method for treating depression through their administration.
Career Highlights
Aldo Ermili is associated with Carlo Erba, a company known for its focus on pharmaceutical innovations. His work at Carlo Erba has allowed him to explore and develop new therapeutic options for mental health treatment. His dedication to research and development has positioned him as a key figure in the pharmaceutical industry.
Collaborations
Throughout his career, Aldo has collaborated with notable colleagues, including Alessandro Balbi and Norina Passerini. These partnerships have fostered a collaborative environment that enhances the innovation process and contributes to the advancement of their shared goals in pharmaceutical research.
Conclusion
Aldo Ermili's contributions to the field of antidepressant compounds highlight his commitment to improving mental health treatment. His innovative patents and collaborations reflect a dedication to advancing pharmaceutical science. His work continues to pave the way for new therapeutic options in the fight against depression.